mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.07 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.095 |
0.07 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.08 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.08 |